ClinicalTrials.Veeva

Menu

Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis

A

Assiut University

Status

Unknown

Conditions

Pancreatitis, Acute

Treatments

Diagnostic Test: High sesitive C reactive protien

Study type

Observational

Funder types

Other

Identifiers

NCT03740685
CHCPWDTM

Details and patient eligibility

About

changes in high sensitive C reactive protien with different treatment modalities in acute pancreatitis

Enrollment

80 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>=18 years

  • Diagnosis of acute pancreatitis confirmed by at least 2 of the following:

    1. Typical epigastric abdominal pain
    2. Elevation amylase/lipase >3 times upper limit normal and/or
    3. Confirmatory findings on cross-sectional imaging
    4. Enrollment within 8 hours of presentation

Exclusion criteria

  • Class II or greater NYHA heart failure
  • Oxygen dependent COPD
  • Chronic kidney disease>stage 2
  • Existing necrosis on abdominal CT
  • Organ dysfunction prior to enrollment
  • Sepsis
  • Acute respiratory distress syndrome
  • Malignancy not in remission for at least 5 years
  • Active drug use
  • Known allergy to dexamethasone
  • Altered mental status
  • Insulin-requiring diabetes
  • Abdominal surgery within 60days

Trial design

80 participants in 1 patient group

Patients with acute pancreatitis
Description:
All patients will recive different lines of treatment {saline,antibiotics,dexamethasone}
Treatment:
Diagnostic Test: High sesitive C reactive protien

Trial contacts and locations

1

Loading...

Central trial contact

mahmoud Abd Elhamed, principal participant

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems